1)Stuck AE, et al:Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11:954-963, 1989
2)Yale SH, et al:Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome:associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5-13, 1996
3)Limper AH, et al:An official American Thoracic Society statement:treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 183:96-128, 2011
4)Katsuyama T, et al:Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. Arthritis Res Ther 16:R43, 2014
5)Solensky R:Drug desensitization. Immunol Allergy Clin North Am 24:425-443, vi, 2004
6)日本骨代謝学会:ステロイド性骨粗鬆症の管理と治療ガイドライン:2014年改訂版,2014
7)Suzuki Y, et al:Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research:2014 update. J Bone Miner Metab 32:337-350, 2014
8)赤穂理絵・他:NPSLEの臨床—精神科の立場から.Brain Nerve 71:473-481, 2019
9)Nishimura K, et al:Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 33:395-403, 2008
10)石井健夫・他:二次性高血圧—薬剤誘発性高血圧.内科125:269-271,2020
11)Conn HO, et al:Corticosteroids and peptic ulcer:meta-analysis of adverse events during steroid therapy. J Intern Med 236:619-632, 1994
12)西山 慶・他:各科におけるステロイド療法のノウハウ—小児科.臨と研96:447-451,2019
13)Broersen LH, et al:Adrenal insufficiency in corticosteroids use:systematic review and meta-analysis. J Clin Endocrinol Metab 100:2171-2180, 2015
14)田村尚久:副腎—副腎皮質機能低下症.コルチコステロイド離脱症候群.日臨(別冊内分泌症候群Ⅱ):27-31,2018
15)寺澤秀一:急性副腎不全の病態と治療—治療の実際.日内会誌97:761-765,2008